Taylor, Cottrill, Erickson & Associates, Inc. Pfizer Inc Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$338 Million
Q2 2024

A detailed history of Taylor, Cottrill, Erickson & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Taylor, Cottrill, Erickson & Associates, Inc. holds 12,450 shares of PFE stock, worth $369,267. This represents 0.1% of its overall portfolio holdings.

Number of Shares

12,450

Previous 12,450 -0.0%

Holding current value

$369,267

Previous $345,000 0.87%

% of portfolio

0.1%

Previous 0.1%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$41.32 - $61.25 $1.28 Million - $1.89 Million	-30,861 Reduced 71.25%	12,450 $735,000
Q2 2021 Jul 20, 2021	BUY	$35.91 - $40.68 $23,341 - $26,442	650 Added 1.52%	43,311 $1.7 Million
Q3 2020 Oct 09, 2020	SELL	$31.75 - $37.25 $19,050 - $22,350	-600 Reduced 1.39%	42,661 $1.57 Million
Q1 2020 Apr 15, 2020	SELL	$27.03 - $38.62 $10,812 - $15,447	-400 Reduced 0.92%	43,261 $1.41 Million
Q4 2019 Jan 14, 2020	SELL	$32.92 - $37.36 $7,077 - $8,032	-215 Reduced 0.49%	43,661 $1.71 Million
Q3 2019 Oct 25, 2019	SELL	$32.49 - $42.13 $42,009 - $54,474	-1,293 Reduced 2.86%	43,876 $1.58 Million
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $25,220 - $28,316	-682 Reduced 1.49%	45,169 $1.96 Million
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $12,750 - $14,008	-340 Reduced 0.74%	45,851 $1.95 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $7,694 - $8,772	-200 Reduced 0.43%	46,191 $2.02 Million
Q1 2018 Apr 23, 2018	SELL	$31.91 - $37.02 $9,573 - $11,106	-300 Reduced 0.64%	46,391 $1.65 Million
Q3 2017 Oct 19, 2017	BUY	$31.0 - $34.15 $1.45 Million - $1.59 Million	46,691	46,691 $1.67 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account

Taylor, Cottrill, Erickson & Associates, Inc. Pfizer Inc Transaction History